OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer
Huan Meng, André E. Nel
Advanced Drug Delivery Reviews (2018) Vol. 130, pp. 50-57
Open Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes
Jiaxuan Xia, Shuya Zhang, Ru Zhang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 37

Struct2Graph: a graph attention network for structure based predictions of protein–protein interactions
Mayank Baranwal, Abram Magner, Jacob C. Saldinger, et al.
BMC Bioinformatics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 35

Biomaterial-Based Responsive Nanomedicines for Targeting Solid Tumor Microenvironments
Konstantinos Avgoustakis, Athina Angelopoulou
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 6

Modification of radiosensitivity by Curcumin in human pancreatic cancer cell lines
Katharina Schwarz, Sophie Dobiasch, Lily Nguyen, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 41

Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance
Michelle K. Greene, Michael C. Johnston, Christopher J. Scott
Cancers (2021) Vol. 13, Iss. 24, pp. 6175-6175
Open Access | Times Cited: 40

Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
Hiroyoshi Tanaka, Takuya Nakazawa, Atsushi Enomoto, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 724-724
Open Access | Times Cited: 14

Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer
Lei Fan, Xinyuan Xi, Surinder K. Batra, et al.
Journal of Pharmacology and Experimental Therapeutics (2019) Vol. 370, Iss. 3, pp. 682-694
Open Access | Times Cited: 42

Harnessing CURATE.AI as a Digital Therapeutics Platform by Identifying N‐of‐1 Learning Trajectory Profiles
Theodore Kee, Chee Weiyan, Agata Blasiak, et al.
Advanced Therapeutics (2019) Vol. 2, Iss. 9
Closed Access | Times Cited: 36

Noninvasive Preclinical Evaluation of Targeted Nanoparticles for the Delivery of Curcumin in Treating Pancreatic Cancer
Prabhuraj R.S., Arijit Mal, Snehal K. Valvi, et al.
ACS Applied Bio Materials (2020) Vol. 3, Iss. 7, pp. 4643-4654
Closed Access | Times Cited: 33

A Tumor‐Penetrating Nanomedicine Improves the Chemoimmunotherapy of Pancreatic Cancer
Qi‐Song Tong, Weimin Miao, Hua Huang, et al.
Small (2021) Vol. 17, Iss. 29
Closed Access | Times Cited: 32

Use of Nanoformulation to Target Macrophages for Disease Treatment
Xiangsheng Liu, Xiaodong Xie, Jinhong Jiang, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 38
Closed Access | Times Cited: 30

Extensive Review of Nanomedicine Strategies Targeting the Tumor Microenvironment in PDAC
Xing Liu, Yidan Shao, Yunjiang Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3379-3406
Open Access

Nanomedicine for Imaging and Therapy of Pancreatic Adenocarcinoma
Giulia Brachi, Federico Bussolino, Gianluca Ciardelli, et al.
Frontiers in Bioengineering and Biotechnology (2019) Vol. 7
Open Access | Times Cited: 32

Engineering extracellular matrix to improve drug delivery for cancer therapy
Xiaocong He, Yuanyuan Yang, Lingxiao Li, et al.
Drug Discovery Today (2020) Vol. 25, Iss. 9, pp. 1727-1734
Closed Access | Times Cited: 32

Injectable corilagin/low molecular weight chitosan/PLGA-PEG-PLGA thermosensitive hydrogels for localized cancer therapy and promoting drug infiltration by modulation of tumor microenvironment
Xin Jin, Qiang Fu, Zehui Gu, et al.
International Journal of Pharmaceutics (2020) Vol. 589, pp. 119772-119772
Closed Access | Times Cited: 30

Gene silencing delivery systems for the treatment of pancreatic cancer: Where and what to target next?
David Větvička, Ladislav Sivák, Chinmay M. Jogdeo, et al.
Journal of Controlled Release (2021) Vol. 331, pp. 246-259
Closed Access | Times Cited: 25

Partial ligand shielding nanoparticles improve pancreatic ductal adenocarcinoma treatment via a multifunctional paradigm for tumor stroma reprogramming
Ting Zhao, Rongping Zhang, Qin He, et al.
Acta Biomaterialia (2022) Vol. 145, pp. 122-134
Closed Access | Times Cited: 18

<p>Mapping Intellectual Structure and Research Performance for the Nanoparticles in Pancreatic Cancer Field</p>
Xuan Zhu, Qingquan Kong, Xing Niu, et al.
International Journal of Nanomedicine (2020) Vol. Volume 15, pp. 5503-5516
Open Access | Times Cited: 26

Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
Raquel Muñoz, Alessandra Girotti, Denise Hileeto, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5414-5414
Open Access | Times Cited: 19

Bioreducible, arginine-rich polydisulfide-based siRNA nanocomplexes with excellent tumor penetration for efficient gene silencing
Xinyue Zhang, K. M. Hong, Qingmei Sun, et al.
Biomaterials Science (2021) Vol. 9, Iss. 15, pp. 5275-5292
Closed Access | Times Cited: 18

Cancer-Associated Fibroblast-Targeted Delivery of Captopril to Overcome Penetration Obstacles for Enhanced Pancreatic Cancer Therapy
Xiaohong Chen, Fan Jia, Yue Huang, et al.
ACS Applied Bio Materials (2022) Vol. 5, Iss. 7, pp. 3544-3553
Closed Access | Times Cited: 14

Stromal Homeostasis-Restoring Nanomedicine Enhances Pancreatic Cancer Chemotherapy
Na Yu, Xi Zhang, Haiping Zhong, et al.
Nano Letters (2022) Vol. 22, Iss. 21, pp. 8744-8754
Closed Access | Times Cited: 14

Nanoparticle-Based Therapeutic Strategies for Enhanced Pancreatic Ductal Adenocarcinoma Immunotherapy
Wanting Hou, Biao Yang, Hong Zhu
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2033-2033
Open Access | Times Cited: 13

Simultaneous Delivery of Dual Inhibitors of DNA Damage Repair Sensitizes Pancreatic Cancer Response to Irreversible Electroporation
Xin Long, Anna Dai, Teng Huang, et al.
ACS Nano (2023) Vol. 17, Iss. 13, pp. 12915-12932
Closed Access | Times Cited: 7

Scroll to top